Risk assessment for and strategies to reduce perioperative pulmonary complications [1]

Annals of Internal Medicine

Volumn 145, Issue 7, 2006, Pages 553-

  Qaseem, Tahir ^a  

^a Presbyterian Healthcare Services   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; PROTON PUMP INHIBITOR; SUCRALFATE;

ABDOMINAL SURGERY; ADULT RESPIRATORY DISTRESS SYNDROME; ASPIRATION PNEUMONIA; COMBINATION CHEMOTHERAPY; EVIDENCE BASED PRACTICE; HUMAN; LARYNX DISORDER; LETTER; LUNG COMPLICATION; NONHUMAN; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RISK ASSESSMENT; STOMACH PH; SURGICAL MORTALITY; LUNG DISEASE; NOTE;

HUMANS; LUNG DISEASES; PNEUMONIA, ASPIRATION; POSTOPERATIVE COMPLICATIONS; RISK ASSESSMENT;

EID: 33750112420     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-145-7-200610030-00017     Document Type: Letter

References (6)

1. Qaseem A, Snow V, Fitterman N, Hornbake ER, Lawrence VA, Smetana GW, et al. Risk assessment for and strategies to reduce perioperative pulmonary complications for patients undergoing noncardiothoracic surgery: a guideline from the American College of Physicians. Ann Intern Med. 2006;144:575-80.
2. Warner MA, Warner ME, Weber JG. Clinical significance of pulmonary aspiration during the perioperative period. Anesthesiology. 1993;78:56-62.
3. Rosenstock C, Møller J, Hauberg A. Complaints related to respiratory events in anaesthesia and intensive care medicine from 1994 to 1998 in Denmark. Acta Anaesthesiol Scand. 2001;45:53-8.
4. Ong BY, Palahniuk RJ, Cumming M. Gastric volume and pH in out-patients. Can Anaesth Soc J. 1978;25:36-9.
5. Talke PO, Solanki DR. Dose-response study of oral famotidine for reduction of gastric acidity and volume in outpatients and inpatients. Anesth Analg. 1993;77:1143-8.
6. Kalinowski CP, Kirsch JR. Strategies for prophylaxis and treatment for aspiration. Best Pract Res Clin Anaesthesiol. 2004;18:719-37.